Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Beta-lactamase inhibitor CB-618 pharmacokinetics-pharmacodynamics characterized with other agents

Sep. 21, 2015

Soluble Nogo-B improves angiogenesis in vitro

Sep. 21, 2015

Novel MAb treats diabetes and fatty liver disease in obesity models

Sep. 21, 2015

Hypoglycemia may be detected by analyzing exhaled breath

Sep. 18, 2015

Phase I/IIa results presented for ChAd-EBO-Z Ebola vaccine

Sep. 18, 2015

Prolyl oligopeptidase inhibitor shows promise for cognitive deficit associated with schizophrenia

Sep. 18, 2015

Proof-of-concept study shows promise of novel antimalarial KAF-156

Sep. 18, 2015

New malaria vaccine trial shows lack of efficacy

Sep. 18, 2015

New mutation in LYRM7 gene associated with complex III deficiency

Sep. 18, 2015

Researchers identify novel mutation in GBE1 gene in a GSD-IV patient

Sep. 17, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...